BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 15475059)

  • 1. Ocular release of timolol from molecularly imprinted soft contact lenses.
    Hiratani H; Fujiwara A; Tamiya Y; Mizutani Y; Alvarez-Lorenzo C
    Biomaterials; 2005 Apr; 26(11):1293-8. PubMed ID: 15475059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlling drug release from imprinted hydrogels by modifying the characteristics of the imprinted cavities.
    Hiratani H; Mizutani Y; Alvarez-Lorenzo C
    Macromol Biosci; 2005 Aug; 5(8):728-33. PubMed ID: 16082622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The nature of backbone monomers determines the performance of imprinted soft contact lenses as timolol drug delivery systems.
    Hiratani H; Alvarez-Lorenzo C
    Biomaterials; 2004 Mar; 25(6):1105-13. PubMed ID: 14615176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temperature sensitive contact lenses for triggered ophthalmic drug delivery.
    Jung HJ; Chauhan A
    Biomaterials; 2012 Mar; 33(7):2289-300. PubMed ID: 22182750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained in vivo release from imprinted therapeutic contact lenses.
    Tieppo A; White CJ; Paine AC; Voyles ML; McBride MK; Byrne ME
    J Control Release; 2012 Feb; 157(3):391-7. PubMed ID: 21982900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Timolol uptake and release by imprinted soft contact lenses made of N,N-diethylacrylamide and methacrylic acid.
    Hiratani H; Alvarez-Lorenzo C
    J Control Release; 2002 Oct; 83(2):223-30. PubMed ID: 12363448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zero-order therapeutic release from imprinted hydrogel contact lenses within in vitro physiological ocular tear flow.
    Ali M; Horikawa S; Venkatesh S; Saha J; Hong JW; Byrne ME
    J Control Release; 2007 Dec; 124(3):154-62. PubMed ID: 17964678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imprinted soft contact lenses as norfloxacin delivery systems.
    Alvarez-Lorenzo C; Yañez F; Barreiro-Iglesias R; Concheiro A
    J Control Release; 2006 Jul; 113(3):236-44. PubMed ID: 16777254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soft contact lenses capable of sustained delivery of timolol.
    Alvarez-Lorenzo C; Hiratani H; Gómez-Amoza JL; Martínez-Pacheco R; Souto C; Concheiro A
    J Pharm Sci; 2002 Oct; 91(10):2182-92. PubMed ID: 12226845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of timolol release from silicone hydrogel model contact lens materials using hyaluronic acid.
    Guidi G; Korogiannaki M; Sheardown H
    Eye Contact Lens; 2014 Sep; 40(5):269-76. PubMed ID: 25162288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo evaluation of ketotifen fumarate-loaded silicone hydrogel contact lenses for ocular drug delivery.
    Xu J; Li X; Sun F
    Drug Deliv; 2011 Feb; 18(2):150-8. PubMed ID: 21043996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo evaluation of novel implantation technology in hydrogel contact lenses for controlled drug delivery.
    Maulvi FA; Lakdawala DH; Shaikh AA; Desai AR; Choksi HH; Vaidya RJ; Ranch KM; Koli AR; Vyas BA; Shah DO
    J Control Release; 2016 Mar; 226():47-56. PubMed ID: 26860285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro controlled release of an anti-inflammatory from daily disposable therapeutic contact lenses under physiological ocular tear flow.
    Tieppo A; Pate KM; Byrne ME
    Eur J Pharm Biopharm; 2012 May; 81(1):170-7. PubMed ID: 22333489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of ocular drug delivery systems using molecularly imprinted soft contact lenses.
    Tashakori-Sabzevar F; Mohajeri SA
    Drug Dev Ind Pharm; 2015 May; 41(5):703-13. PubMed ID: 25113431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended delivery of ophthalmic drugs by silicone hydrogel contact lenses.
    Kim J; Conway A; Chauhan A
    Biomaterials; 2008 May; 29(14):2259-69. PubMed ID: 18289662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glaucoma therapy by extended release of timolol from nanoparticle loaded silicone-hydrogel contact lenses.
    Jung HJ; Abou-Jaoude M; Carbia BE; Plummer C; Chauhan A
    J Control Release; 2013 Jan; 165(1):82-9. PubMed ID: 23123188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timolol transport from microemulsions trapped in HEMA gels.
    Li CC; Abrahamson M; Kapoor Y; Chauhan A
    J Colloid Interface Sci; 2007 Nov; 315(1):297-306. PubMed ID: 17673246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Via zinc(II) protoporphyrin to the synthesis of poly(ZnPP-MAA-EGDMA) for the imprinting and selective binding of bilirubin.
    Chou SK; Syu MJ
    Biomaterials; 2009 Mar; 30(7):1255-62. PubMed ID: 19100614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-1beta tear concentration in glaucomatous and ocular hypertensive patients treated with preservative-free nonselective beta-blockers.
    Manni G; Centofanti M; Oddone F; Parravano M; Bucci MG
    Am J Ophthalmol; 2005 Jan; 139(1):72-7. PubMed ID: 15652830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-Reporting Colorimetric Analysis of Drug Release by Molecular Imprinted Structural Color Contact Lens.
    Deng J; Chen S; Chen J; Ding H; Deng D; Xie Z
    ACS Appl Mater Interfaces; 2018 Oct; 10(40):34611-34617. PubMed ID: 30211539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.